Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2014-03-11 23:09:38 |
Versijas komentārs | |
Teksts |
Fourth Quarter 2013 Investor Conference Webinar
On March 11 AS „Olainfarm” organized its fourth quarter 2013
Investor Conference Online Webinar. During the webinar the member
of the management board of AS „Olainfarm” Salvis Lapiņš analysed
the financial results of fourth quarter and full year of 2013 and
informed about the company’s future
activities.
He also informed that the Government of Latvia has agreed to
provide a tax rebate for AS “Olainfarm”, if company executes
certain CAPEX program. Currently the CAPEX plan for the two
years to come amounts to 40 million euros. The investments will be
made in building a new production site and energy efficiency
improvements (cooling station etc). Also in long term AS
“Olainfarm” considers a possibility to make an acquisition of a
pharmaceutical company doing its business outside CIS region but
does not have any specific plans yet.
According to Salvis Lapiņš considering AS “Olainfarm”
investment plans the Board of the company will propose to put
dividend payments on hold for the profits of 2013 and 2014 and to
restart it from the profits made in 2015, with a payout ratio of
17.5%
As for sales -very preliminary data shows, that sales to Ukraine in
February were in the area of 700 000 EUR. For internal planning
purposes AS “Olainfarm” plans a short term stop in growth of sales
in Russia and the sales of about 0.7 to 1 million euros a month to
Ukraine.
Answering the questions sent in by the investors, Salvis Lapiņš
provided information about the patents, indicating that in total
company has 13 patents with different validity periods, starting
with 4 and up to 18 years. He also confirmed that the topic of
company’s share split is still to be discussed and AS “Olainfarm”
might come back to this in autumn.
The recorded “Olainfarm” webinar is available online:
http://ej.uz/Olainfarm_4Q_2014,
and the presentation,
demonstrated during the webinar, can be found in the previously
published AS “Olainfarm” announcement: https://newsclient.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=598440&messageId=740791.
Olainfarm thanks all participants, who joined the webinar, and
encourages everybody to follow company’s announcements to get
information on the next webinar!
A/s
OlainFarm is one of the biggest pharmaceutical companies in Latvia
with 40 years of experience in production of medication and
chemical and pharmaceutical products. A basic principle of
company's operations is to produce reliable and effective top
quality products for Latvia and the rest of the world. Products
made by the Group are being exported to more than 30 countries of
the world, including the Baltics, Russia, other CIS, Europe, Asia,
North America and Australia. |
Pielikumi |
|